Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q28377487)
Watch
English
Comparison of inhaled salmeterol and oral zafirlukast in patients with asthma
scientific article
In more languages
edit
Statements
instance of
scholarly article
0 references
title
Comparison of inhaled salmeterol and oral zafirlukast in patients with asthma
(English)
0 references
main subject
asthma
0 references
zafirlukast
1 reference
based on heuristic
inferred from title
author name string
W Busse
series ordinal
1
0 references
H Nelson
series ordinal
2
0 references
J Wolfe
series ordinal
3
0 references
C Kalberg
series ordinal
4
0 references
S W Yancey
series ordinal
5
0 references
K A Rickard
series ordinal
6
0 references
language of work or name
English
0 references
publication date
June 1999
0 references
published in
The Journal of Allergy and Clinical Immunology
0 references
volume
103
0 references
issue
6
0 references
page(s)
1075-80
0 references
cites work
Effects of 6 weeks of therapy with oral doses of ICI 204,219, a leukotriene D4 receptor antagonist, in subjects with bronchial asthma. ACCOLATE Asthma Trialists Group
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970182-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Zafirlukast for symptomatic mild-to-moderate asthma: a 13-week multicenter study. The Zafirlukast Trialists Group
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970182-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Effectiveness of the leukotriene receptor antagonist zafirlukast for mild-to-moderate asthma. A randomized, double-blind, placebo-controlled trial.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970182-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, November 1986
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970182-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Lung function testing: selection of reference values and interpretative strategies. American Thoracic Society
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970182-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Cysteinyl leukotrienes in asthma: old mediators up to new tricks
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970182-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The role of leukotrienes in inflammation
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970182-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Leukotriene activity modulation in asthma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970182-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Salmeterol: a potent and long-acting inhibitor of inflammatory mediator release from human lung
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970182-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Salmeterol: a novel, long-acting beta 2-agonist
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970182-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Identifiers
DOI
10.1016/S0091-6749(99)70182-X
0 references
PubMed ID
10359889
0 references
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit